{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:27Z","timestamp":1789519587211,"version":"build-2803163510"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.retram.2023.103389","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T20:22:08Z","timestamp":1680726128000},"page":"103389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia"],"prefix":"10.1016","volume":"71","author":[{"given":"Masoud","family":"Kargar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Torabizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-2686","authenticated-orcid":false,"given":"Daryush","family":"Purrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Deris","family":"Zayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0001","first-page":"139","article-title":"Prevalence of cytomegalovirus (CMV) and epstein-barr virus (EBV) subclinical infection in patients with acute immune thrombocytopenic purpura (ITP)","volume":"15","author":"Abbasi","year":"2021","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"issue":"8","key":"10.1016\/j.retram.2023.103389_bib0002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10245332.2018.1435021","article-title":"Immune dysregulation in primary immune thrombocytopenia patients","volume":"23","author":"Zhang","year":"2018","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0003","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.26045","article-title":"Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment","volume":"96","author":"Cooper","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.retram.2023.103389_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104096","article-title":"CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia","volume":"351","author":"Kostic","year":"2020","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari","year":"2013","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.critrevonc.2004.12.004","article-title":"Multi-dysfunctional pathophysiology in ITP","volume":"54","author":"Zhou","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.retram.2023.103389_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/521957","article-title":"Functional and phenotypic plasticity of CD4+ T cell subsets","volume":"2015","author":"Caza","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.retram.2023.103389_bib0008","doi-asserted-by":"crossref","unstructured":"Semple J.W., Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. 1991.","DOI":"10.1182\/blood.V78.10.2619.bloodjournal78102619"},{"issue":"6","key":"10.1016\/j.retram.2023.103389_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune thrombocytopenia: recent advances in pathogenesis and treatments","volume":"5","author":"Audia","year":"2021","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.retram.2023.103389_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.thromres.2019.03.005","article-title":"Aberrant expression of microRNA in CD4+ cells contributes to Th17\/Treg imbalance in primary immune thrombocytopenia","volume":"177","author":"Hua","year":"2019","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0012","first-page":"730","article-title":"Imbalance of Th17\/Treg cells ratio in peripheral blood of patients with immune thrombocytopenia","volume":"19","author":"Cao","year":"2011","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0013","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1007\/s00431-021-04121-z","article-title":"Increased proportion of Th17\/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center","volume":"180","author":"Gu","year":"2021","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.retram.2023.103389_bib0014","doi-asserted-by":"crossref","first-page":"e50909","DOI":"10.1371\/journal.pone.0050909","article-title":"The ratio of Treg\/Th17 cells correlates with the disease activity of primary immune thrombocytopenia","volume":"7","author":"Ji","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cei.12279","article-title":"Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)","volume":"176","author":"Talaat","year":"2014","journal-title":"Clinic. Exp. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0016","series-title":"Seminars in Hematology","article-title":"T cells in the pathogenesis of immune thrombocytopenia","year":"2016"},{"key":"10.1016\/j.retram.2023.103389_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1064-9","article-title":"Pulsed high-dose dexamethasone modulates Th1-\/Th2-chemokine imbalance in immune thrombocytopenia","volume":"14","author":"Liu","year":"2016","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.retram.2023.103389_bib0018","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20170155","article-title":"The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination","volume":"215","author":"Yu","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.retram.2023.103389_bib0019","doi-asserted-by":"crossref","unstructured":"Semple J.W., Milev Y., Cosgrave D., Mody M., Hornstein A., Blanchette V., et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. 1996.","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245"},{"key":"10.1016\/j.retram.2023.103389_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0021","article-title":"Immunomodulatory effects of TGF-\u03b2 in the patients with immune thrombocytopenia","volume":"59","author":"Kosti\u0107","year":"2020","journal-title":"Acta Med. Medianae"},{"issue":"7","key":"10.1016\/j.retram.2023.103389_bib0022","first-page":"914","article-title":"Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura","volume":"90","author":"Wang","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur. J. Haematol."},{"issue":"7","key":"10.1016\/j.retram.2023.103389_bib0024","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103389_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-017-0210-3","article-title":"The cytokine polymorphisms affecting Th1\/Th2 increase the susceptibility to, and severity of, chronic ITP","volume":"18","author":"Takahashi","year":"2017","journal-title":"BMC Immunol."},{"issue":"10","key":"10.1016\/j.retram.2023.103389_bib0026","doi-asserted-by":"crossref","first-page":"e26522","DOI":"10.1371\/journal.pone.0026522","article-title":"Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia","volume":"6","author":"Hu","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0027","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.imbio.2017.10.023","article-title":"Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: impact of interleukin-7","volume":"223","author":"Kielsen","year":"2018","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.retram.2023.103389_bib0028","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","article-title":"Th17 cells in inflammation and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.retram.2023.103389_bib0029","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-016-0014-5","article-title":"GM-CSF as a therapeutic target in autoimmune diseases","volume":"36","author":"Shiomi","year":"2016","journal-title":"Inflamm. Regen."},{"issue":"16","key":"10.1016\/j.retram.2023.103389_bib0031","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.4161\/15384101.2014.946377","article-title":"Autoimmunity beyond Th17: GM-CSF producing T cells","volume":"13","author":"Zielinski","year":"2014","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.retram.2023.103389_bib0032","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.transci.2018.10.018","article-title":"Flow cytometry and immune thrombocytopenic purpura","volume":"57","author":"Goubran","year":"2018","journal-title":"Transfus Apher. Sci."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0033","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.retram.2023.103389_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3758713","article-title":"Description of CD8+ regulatory T lymphocytes and their specific intervention in graft-versus-host and infectious diseases, autoimmunity, and cancer","volume":"2018","author":"Vieyra-Lobato","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/labinvest.2014.142","article-title":"Inactivation of Notch signaling reverses the Th17\/Treg imbalance in cells from patients with immune thrombocytopenia","volume":"95","author":"Yu","year":"2015","journal-title":"Lab. Invest."},{"key":"10.1016\/j.retram.2023.103389_bib0036","article-title":"HUWE1 causes an immune imbalance in immune thrombocytopenic purpura by reducing the number and function of treg cells through the ubiquitination degradation of ets-1","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.retram.2023.103389_bib0037","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","article-title":"Thymic retention of CD4+ CD25+ FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia","volume":"120","author":"Aslam","year":"2012","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.retram.2023.103389_bib0038","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.3390\/ijms21197015","article-title":"Treg enhancing therapies to treat autoimmune diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0039","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/imm.12994","article-title":"Micro RNA-mediated regulation of T helper type 17\/regulatory T-cell balance in autoimmune disease","volume":"155","author":"Liu","year":"2018","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.132","article-title":"Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation","volume":"49","author":"Jang","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0041","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MBC.0000000000000423","article-title":"Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia","volume":"27","author":"Zhou","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.retram.2023.103389_bib0042","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12185-017-2392-0","article-title":"Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia","volume":"107","author":"Zhang","year":"2018","journal-title":"Int. J. Hematol."},{"issue":"13","key":"10.1016\/j.retram.2023.103389_bib0043","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.7150\/ijbs.33779","article-title":"Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.retram.2023.103389_bib0044","first-page":"493","article-title":"Assessment of Th17\/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model","volume":"22","author":"Zhang","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.retram.2023.103389_bib0045","unstructured":"Arandi N., Mirshafiey A., J.E.D.D.I. TM, Shaghaghi M., Sadeghi B., Abolhassani H., et al. Alteration in frequency and function of CD4+ CD25+ FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura. 2014."},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0046","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ni.3271","article-title":"T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex","volume":"16","author":"Beringer","year":"2015","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0047","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","article-title":"Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.retram.2023.103389_bib0048","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fimmu.2020.00624","article-title":"Regulation of T helper cell fate by TCR signal strength","volume":"11","author":"Bhattacharyya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0049","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10875-019-00632-5","article-title":"Genetic deficiency and biochemical inhibition of ITK affect human Th17, Treg, and innate lymphoid cells","volume":"39","author":"Eken","year":"2019","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20131459","article-title":"Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells","volume":"211","author":"Gomez-Rodriguez","year":"2014","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0051","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni1400","article-title":"Disruption of diacylglycerol metabolism impairs the induction of T cell anergy","volume":"7","author":"Olenchock","year":"2006","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0052","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.20050903","article-title":"LAT-mediated signaling in CD4+ CD25+ regulatory T cell development","volume":"203","author":"Koonpaew","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0053","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.12841","article-title":"Impaired T cell receptor signaling and development of T cell\u2013mediated autoimmune arthritis","volume":"294","author":"Takeuchi","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.retram.2023.103389_bib0054","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.4049\/jimmunol.179.10.6836","article-title":"Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development","volume":"179","author":"Willoughby","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/imr.12148","article-title":"Signals and pathways controlling regulatory T cells","volume":"258","author":"Huynh","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.retram.2023.103389_bib0056","first-page":"2020","article-title":"The function and role of the Th17\/Treg cell balance in inflammatory bowel disease","author":"Yan","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.retram.2023.103389_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109096","article-title":"Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development","volume":"35","author":"Zhang","year":"2021","journal-title":"Cell Rep."},{"issue":"7455","key":"10.1016\/j.retram.2023.103389_bib0058","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature12199","article-title":"BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis","volume":"498","author":"Roychoudhuri","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0059","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-019-14112-2","article-title":"Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis","volume":"11","author":"Sidwell","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0061","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2050640617716596","article-title":"Bach2 repression mediates Th17 cell induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis","volume":"6","author":"Sasikala","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0062","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41385-020-0258-x","article-title":"Protein kinase 2 (CK2) controls CD4+ T cell effector function in the pathogenesis of colitis","volume":"13","author":"Yang","year":"2020","journal-title":"Mucosal. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0063","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.2009.00843.x","article-title":"Organization of proximal signal initiation at the TCR: CD3 complex","volume":"232","author":"Guy","year":"2009","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0064","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.retram.2023.103389_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2016.02.004","article-title":"CD28 costimulatory signals in T lymphocyte activation: emerging functions beyond a qualitative and quantitative support to TCR signalling","volume":"28","author":"Porciello","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0066","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.retram.2023.103389_bib0067","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-020-00202-z","article-title":"The correlation between the Th17\/Treg cell balance and bone health","volume":"17","author":"Zhu","year":"2020","journal-title":"Immun. Ageing"},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0069","doi-asserted-by":"crossref","first-page":"e5087","DOI":"10.1371\/journal.pone.0005087","article-title":"CD28 co-stimulation down regulates Th17 development","volume":"4","author":"Bouguermouh","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.retram.2023.103389_bib0070","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.celrep.2018.02.044","article-title":"IL-23 and IL-1\u03b2 drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation","volume":"22","author":"Revu","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0071","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat. Immunol."},{"issue":"14","key":"10.1016\/j.retram.2023.103389_bib0072","article-title":"In vivo induction of regulatory T Cells Via CTLA-4 signaling peptide to control autoimmune encephalomyelitis and prevent disease relapse","volume":"8","author":"Kim","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.retram.2023.103389_bib0073","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0074","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/21645515.2017.1342913","article-title":"Percentages of PD-1+ CD4+ T cells and PD-L1+ DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia","volume":"14","author":"Wang","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/10245332.2016.1155347","article-title":"Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP","volume":"21","author":"Zhong","year":"2016","journal-title":"Hematology"},{"issue":"43","key":"10.1016\/j.retram.2023.103389_bib0076","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017608","article-title":"PD-1\/PD-L1 pathway activation restores the imbalance of Th1\/Th2 and treg\/Th17 cells subtypes in immune thrombocytopenic purpura patients","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine"},{"issue":"05","key":"10.1016\/j.retram.2023.103389_bib0077","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0039-1679909","article-title":"PD-1\/PD-L pathway potentially involved in ITP immunopathogenesis","volume":"119","author":"Nie","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.retram.2023.103389_bib0078","series-title":"Notch signaling in embryology and cancer: notch signaling in cancer","first-page":"69","article-title":"Notch signaling and liver cancer","author":"Kawaguchi","year":"2021"},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0079","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-2478(01)00326-1","article-title":"Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice","volume":"81","author":"Yamaguchi","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.retram.2023.103389_bib0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00277-009-0790-y","article-title":"Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura","volume":"89","author":"Ma","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.retram.2023.103389_bib0081","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12288-015-0570-x","article-title":"Correlation of Notch1\/Hes1 genes expression levels in Egyptian paediatric patients with newly diagnosed and persistent primary immune (idiopathic) thrombocytopenic purpura","volume":"32","author":"Gawdat","year":"2016","journal-title":"Indian J. Hematol. Blood Transfus"},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02770903.2016.1266494","article-title":"Th17\/Treg dysregulation in allergic asthmatic children is associated with elevated notch expression","volume":"55","author":"Li","year":"2018","journal-title":"J. Asthma"},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0083","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/16078454.2021.1974200","article-title":"Decreasing lncRNA PVT1 causes Treg\/Th17 imbalance via NOTCH signaling in immune thrombocytopenia","volume":"26","author":"Yu","year":"2021","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01187-5","article-title":"Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin","volume":"19","author":"Ghetti","year":"2020","journal-title":"Mol. Cancer"},{"issue":"07","key":"10.1016\/j.retram.2023.103389_bib0085","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1160\/TH-16-06-0481","article-title":"Plasma microRNAs characterising patients with immune thrombo cytopenic purpura","volume":"117","author":"Zuo","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0086","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2012-12-471250","article-title":"MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP)","volume":"121","author":"Jern\u00e5s","year":"2013","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.retram.2023.103389_bib0087","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/epi-2021-0092","article-title":"Dysregulated expression of miRNAs in immune thrombocytopenia","volume":"13","author":"Jafarzadeh","year":"2021","journal-title":"Epigenomics"},{"issue":"47","key":"10.1016\/j.retram.2023.103389_bib0088","doi-asserted-by":"crossref","first-page":"76453","DOI":"10.18632\/oncotarget.12949","article-title":"The aberrant expression of microRNAs and correlations with T cell subsets in patients with immune thrombocytopenia","volume":"7","author":"Liu","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0089","first-page":"411","article-title":"Expression of miR-106b-5p in children with primary immune thrombocytopenia and its correlation with T cells. Zhongguo Dang dai er ke za zhi=","volume":"24","author":"Wang","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0090","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/15384101.2020.1746485","article-title":"miR-106b-5p induces immune imbalance of Treg\/Th17 in immune thrombocytopenic purpura through NR4A3\/Foxp3 pathway","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.retram.2023.103389_bib0091","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s13577-021-00547-7","article-title":"Bone marrow mesenchymal stem cell-derived exosomes induce the Th17\/Treg imbalance in immune thrombocytopenia through miR-146a-5p\/IRAK1 axis","volume":"34","author":"He","year":"2021","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0092","first-page":"772","article-title":"MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.retram.2023.103389_bib0093","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.biopha.2016.07.057","article-title":"Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg\/Th17 in immune thrombocytopenic purpura","volume":"83","author":"Li","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0094","first-page":"588","article-title":"Pathogenesis of immune thrombocytopenic Purpura (ITP) by MiRNA-30a-mediated Th17 cell differentiation","volume":"28","author":"Wu","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.retram.2023.103389_bib0095","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221093595","article-title":"The extensive regulation of MicroRNA in immune thrombocytopenia","volume":"28","author":"Zhao","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0096","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41374-020-00515-z","article-title":"Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation","volume":"101","author":"Li","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.retram.2023.103389_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-019-1289-6","article-title":"Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells","volume":"36","author":"Hirano","year":"2019","journal-title":"Med. Oncol."},{"issue":"13","key":"10.1016\/j.retram.2023.103389_bib0098","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.RA118.005135","article-title":"The orphan nuclear receptor Nor1\/Nr4a3 is a negative regulator of \u03b2-cell mass","volume":"294","author":"Close","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0099","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ni.2520","article-title":"Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis","volume":"14","author":"Sekiya","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0100","first-page":"3203","article-title":"miR\u2011106b\u20115p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma","volume":"19","author":"He","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0101","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000486811","article-title":"Differential expression of MiR-106b-5p and MiR-200c-3p in newly diagnosed versus chronic primary immune thrombocytopenia patients based on systematic analysis","volume":"45","author":"Qian","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.retram.2023.103389_bib0102","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.omtn.2021.07.010","article-title":"miR-99a regulates CD4+ T cell differentiation and attenuates experimental autoimmune encephalomyelitis by mTOR-mediated glycolysis","volume":"26","author":"Gu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0103","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.15252\/embj.201489589","article-title":"Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation","volume":"34","author":"Warth","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.retram.2023.103389_bib0104","first-page":"2020","article-title":"Th17\/Treg imbalance and atherosclerosis","author":"He","year":"2020","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0106","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119223","article-title":"The effects of post-translational modifications on Th17\/Treg cell differentiation","author":"Le Menn","year":"2022","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.retram.2023.103389_bib0108","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00109-018-1662-5","article-title":"Expression of IL-17F is associated with non-pathogenic Th17 cells","volume":"96","author":"Wanke","year":"2018","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0109","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.0904100","article-title":"Smad2 and Smad3 are redundantly essential for the TGF-\u03b2\u2013mediated regulation of regulatory T plasticity and Th1 development","volume":"185","author":"Takimoto","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/JLB.5AB0521-621RR","article-title":"Decreased levels of immune-regulatory cytokines in patients with immune thrombocytopenia and long-lasting overexpression of these cytokines in the splenectomized patients","volume":"110","author":"Wang","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0111","first-page":"694","article-title":"The cytokines (IFN-\u03b3, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-\u03b21) levels in adults with immune thrombocytopenia","volume":"69","author":"Ma","year":"2014","journal-title":"Die Pharmazie"},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0112","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.22984","article-title":"Reduced expression of transforming growth factor-\u03b21 and correlated elevation of interleukin-17 and interferon-\u03b3 in pediatric patients with chronic primary immune thrombocytopenia (ITP)","volume":"57","author":"Wang","year":"2011","journal-title":"Pediatr. Blood. Cancer"},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0113","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.15034","article-title":"Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP 3\/NF-\u03baB\/SMAD pathway in patients with immune thrombocytopenia","volume":"180","author":"He","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0114","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00109-021-02083-1","article-title":"Expression and function of Smad7 in autoimmune and inflammatory diseases","volume":"99","author":"Hu","year":"2021","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.immuni.2008.12.010","article-title":"Interleukin-17A and interleukin-17F: a tale of two cytokines","volume":"30","author":"Dubin","year":"2009","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0116","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1182\/blood.V112.11.4537.4537","article-title":"Elevated expression of IL-17 and IL-23 in patients with immune thrombocytopenic purpura","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117704","article-title":"The role of IL-23\/Th17 pathway in patients with primary immune thrombocytopenia","volume":"10","author":"Ye","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0118","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0119","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cytogfr.2015.07.005","article-title":"Insights into IL-23 biology: from structure to function","volume":"26","author":"Floss","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.retram.2023.103389_bib0120","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"IL-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0121","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00011-020-01339-9","article-title":"Interleukin 23 and autoimmune diseases: current and possible future therapies","volume":"69","author":"Abdo","year":"2020","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.retram.2023.103389_bib0122","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1073\/pnas.1206048110","article-title":"MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling","volume":"110","author":"Chang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0123","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cbin.10220","article-title":"Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura","volume":"38","author":"Zhang","year":"2014","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0124","first-page":"465","article-title":"Effects of the interleukin-21 expression in patients with immune thrombocytopenia and its regulation by high-dose dexamethasone","volume":"23","author":"Zhang","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"48","key":"10.1016\/j.retram.2023.103389_bib0125","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.retram.2023.103389_bib0126","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3389\/fimmu.2019.01865","article-title":"IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients","volume":"10","author":"Shi","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0127","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.20041179","article-title":"Essential role for interleukin-2 for CD4+ CD25+ T regulatory cell development during the neonatal period","volume":"201","author":"Bayer","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","article-title":"IL-2 receptor \u03b2-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells","volume":"178","author":"Burchill","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.retram.2023.103389_bib0129","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.4049\/jimmunol.181.5.3285","article-title":"IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development","volume":"181","author":"Vang","year":"2008","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.retram.2023.103389_bib0130","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.4049\/jimmunol.1402144","article-title":"Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells","volume":"193","author":"Marshall","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0131","first-page":"4919","article-title":"IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+ Foxp3+ regulatory T lymphocytes","author":"Apert","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0132","first-page":"121","article-title":"Serum IL-2 and platelet-associated immunoglobulins are good prognostic markers in immune thrombocytopenic purpura","volume":"11","author":"Rashed","year":"2004","journal-title":"Egypt. J. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0133","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000931","article-title":"Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE","volume":"8","author":"Laurent","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.retram.2023.103389_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155078","article-title":"Increased levels of IL-10 and IL-1Ra counterbalance the proinflammatory cytokine pattern in acute pediatric immune thrombocytopenia","volume":"130","author":"Goelz","year":"2020","journal-title":"Cytokine"},{"issue":"1\u20132","key":"10.1016\/j.retram.2023.103389_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0955-3886(00)00004-7","article-title":"Comparison of platelet immunity in patients with SLE and with ITP","volume":"22","author":"Lazarus","year":"2000","journal-title":"Transfus. Sci."},{"issue":"7","key":"10.1016\/j.retram.2023.103389_bib0136","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4049\/jimmunol.2000612","article-title":"Dynamic roles for IL-2\u2013STAT5 signaling in effector and regulatory CD4+ T cell populations","volume":"205","author":"Jones","year":"2020","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0137","doi-asserted-by":"crossref","first-page":"10888","DOI":"10.1038\/ncomms10888","article-title":"IL-15-dependent balance between Foxp3 and ROR\u03b3t expression impacts inflammatory bowel disease","volume":"7","author":"Tosiek","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0138","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0609.2007.00917.x","article-title":"Circulating dendritic cells subsets and CD4+ Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome","volume":"79","author":"Ling","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.retram.2023.103389_bib0139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10875-007-9111-1","article-title":"Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura","volume":"27","author":"Guo","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.retram.2023.103389_bib0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.004","article-title":"Dexamethasone suppresses the Th17\/1 cell polarization in the CD4+ T cells from patients with primary immune thrombocytopenia","volume":"190","author":"Li","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.retram.2023.103389_bib0141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-023-00987-x","article-title":"Research on the mechanism of prednisone in the treatment of ITP via VIP\/PACAP-mediated intestinal immune dysfunction","volume":"28","author":"Yan","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0142","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/09537104.2019.1624709","article-title":"Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)","volume":"31","author":"Kapur","year":"2020","journal-title":"Platelets."},{"key":"10.1016\/j.retram.2023.103389_bib0143","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cyto.2017.01.013","article-title":"Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia","volume":"92","author":"M-m","year":"2017","journal-title":"Cytokine"},{"issue":"22","key":"10.1016\/j.retram.2023.103389_bib0144","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","article-title":"Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents","volume":"116","author":"Bao","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103389_bib0145","series-title":"Seminars in hematology","article-title":"Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia?","author":"Schifferli","year":"2016"},{"issue":"4","key":"10.1016\/j.retram.2023.103389_bib0146","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell\u2013depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103389_bib0147","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-010-0753-z","article-title":"Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia","volume":"93","author":"Li","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"8","key":"10.1016\/j.retram.2023.103389_bib0148","doi-asserted-by":"crossref","first-page":"e71882","DOI":"10.1371\/journal.pone.0071882","article-title":"Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway","volume":"8","author":"Crow","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.retram.2023.103389_bib0149","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","article-title":"Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function","volume":"179","author":"Kessel","year":"2007","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.retram.2023.103389_bib0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2011.02.007","article-title":"Comparison of different IVIg preparations on IL-17 production by human Th17 cells","volume":"10","author":"Maddur","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.retram.2023.103389_bib0151","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10875-012-9752-6","article-title":"Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations","volume":"33","author":"Maddur","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.retram.2023.103389_bib0152","doi-asserted-by":"crossref","first-page":"e28075","DOI":"10.1002\/pbc.28075","article-title":"Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia","volume":"67","author":"Wang","year":"2020","journal-title":"Pediatr. Blood. Cancer"},{"key":"10.1016\/j.retram.2023.103389_bib0153","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.intimp.2019.04.061","article-title":"The potential therapeutic benefit of resveratrol on Th17\/Treg imbalance in immune thrombocytopenic purpura","volume":"73","author":"Guo","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.retram.2023.103389_bib0154","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cyto.b.21494","article-title":"Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia","volume":"94","author":"Zhang","year":"2018","journal-title":"Cytometry Part B"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:41:08Z","timestamp":1762821668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2452318623000132"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103389","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103389"}}